We are live on ! Find out more
ELMD icon

Electromed

27.68 USD
+0.40
1.47%
At close Updated Oct 29, 4:00 PM EDT
Pre-market
After hours
27.68
0.00
0%
1 day
1.47%
5 days
3.59%
1 month
-2.29%
3 months
-31.08%
6 months
10.28%
Year to date
1.06%
1 year
15.29%
5 years
152.09%
10 years
580.1%
 

About: Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.

Employees: 197

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 25%
Neutral 75%
Negative 0%
Neutral
Business Wire
2 days ago
Electromed, Inc. to Report Q1 Fiscal 2027 Financial Results on November 10, 2026
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Report Q1 Fiscal 2027 Financial Results on November 10, 2026.
Electromed, Inc. to Report Q1 Fiscal 2027 Financial Results on November 10, 2026
Neutral
Business Wire
1 month ago
Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event.
Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event
Positive
Seeking Alpha
2 months ago
Electromed: Contrarian 'Buy' With SmartVest
Electromed's direct-to-patient model, broad payer coverage, and disciplined sales execution support durable SmartVest growth. The bronchiectasis market remains substantially underpenetrated, leaving a long runway for greater HFCWO adoption. Hospital revenue is volatile, but the channel remains small and full-year hospital sales still increased.
Electromed: Contrarian 'Buy' With SmartVest
Neutral
Seeking Alpha
2 months ago
Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript
Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript
Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript
Positive
Zacks Investment Research
2 months ago
Electromed, Inc. (ELMD) Surpasses Q4 Earnings Estimates
Electromed, Inc. (ELMD) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.25 per share a year ago.
Electromed, Inc. (ELMD) Surpasses Q4 Earnings Estimates
Neutral
Business Wire
2 months ago
Electromed Announces CEO's Planned Retirement
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed Announces CEO's Planned Retirement.
Electromed Announces CEO's Planned Retirement
Neutral
Business Wire
2 months ago
Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results.
Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results
Neutral
Business Wire
2 months ago
Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026.
Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026
Positive
Zacks Investment Research
3 months ago
4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX
LQDA, FLXS, ELMD and AGX combine low beta, positive price momentum and strong fundamentals to help investors navigate market volatility.
4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX
Positive
Zacks Investment Research
3 months ago
Electromed (ELMD) Is a Great Choice for 'Trend' Investors, Here's Why
Electromed (ELMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Electromed (ELMD) Is a Great Choice for 'Trend' Investors, Here's Why
Price charts implemented using Lightweight Charts™